You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
舒泰神(300204.SZ):間接參投企業前沿生物科創板IPO順利過會
格隆匯 08-07 19:42

格隆匯 8 月 7日丨舒泰神(300204.SZ)公佈,公司於2018年06月08日召開第三屆董事會第二十七次會議,審議通過了《關於全資子公司舒泰神香港投資有限公司使用自有資金參與投資私募股權基金的議案》,為進一步加強公司在醫藥領域的投資和產業佈局,舒泰神的全資子公司舒泰神香港投資有限公司(“舒泰神香港”)使用自有資金500萬美元參與投資Blue Ocean Private Equity I LP(一家註冊地在開曼羣島的私募股權基金,“BlueOcean”“基金”),該基金將投資於海內外醫藥高科技企業項目。

2019年08月,Blue Ocean使用自有資金投資的前沿生物藥業(南京)股份有限公司(“前沿生物”)向上海證券交易所提交了首次公開發行股票並在科創板上市的申請材料,上海證券交易所於2019年08月13日予以受理。

近日,公司及全資子公司舒泰神香港從Blue Ocean Private Equity I LP處獲悉,上海證券交易所科創板股票上市委員會於2020年08月06日對前沿生物發行上市申請進行了審議,根據審議結果,同意前沿生物發行上市(首發)。前沿生物將根據中國證監會及上海證券交易所的相關規定及要求開展後續工作。

截至公告披露日,Blue Ocean出資8000萬元(或等額美元)認購前沿生物400萬股股份,持股比例佔前沿生物發行前總股本的1.48%;公司全資子公司舒泰神香港對Blue Ocean的出資額為500萬美元(含管理費等),間接持股比例約佔前沿生物發行前總股本的0.57%。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account